DSS - DSS Inc.’s (NYSE American: DSS) Subsidiary Appoints New Chief Investment Officer to Aggressively Develop Mutual Fund Business for Eventual Spinoff
(NewsDirect)
By David Willey, Benzinga
DSS Wealth, Inc. has appointed Daniel Lew as its new Chief InvestmentOfficer (CIO) and Portfolio Manager . DSS Wealth is a mutualfund and a wholly-owned subsidiary of DSS, Inc. (NYSE American:DSS), a multinational that looks to increase shareholder value throughincubating and spinning off potentially lucrative companies. DSS, Inc.operates around 40 companies through 9 divisions targeted forhigh-growth potential, including healthcare, real estate and renewableenergy.
As itsnew CIO, Lew will manage DSS Wealth's investment strategies,resource allocation, and risk management to achieve clients'financial goals. He has several decades of experience managinginvestments, as well as in security analysis and institutional clientadvisory. Senior investment management positions he has held includethose at companies like AIG SunAmerica, Strong Capital, John HsuCapital, Citizens Advisers and Equitable Capital.
Along with hismanagement positions, Lew has also consulted for institutional fundsat both William M. Mercer and RogersCasey. Lew’s appointmentreflects DSS Wealth's commitments both to attracting top talentand to providing their clients with outstanding investment solutionsand personalized service.
Daniel Lew, said, "I joined DSS Wealth, Inc. with themission to build a strong, seasoned team that will deliver better fundperformance for DSS AmericaFirst Fund shareholders and to grow assetsunder management. I am excited that the stock market has been strong,largely driven by a select group of the largest stocks (TheMagnificent Seven) in the first half, and now we are seeing signs ofbreadth expanding to undervalued stocks, especially high dividend andsmaller caps. Expanding breadth is usually a strong bullish sign thatstocks have much further to run. There is currently over $5 trillionin assets sitting in money market funds to add fuel to thefire."
Promoting DSS’ Mission
As its new PortfolioManager, Daniel Lew will leverage his wide-ranging industry experienceto drive investment decisions and generate superior returns forclients of DSS Wealth. The company also advises DSS AmericaFirst QuantitativeFunds , which approaches investing by using a uniquequantitative approach that helps the fund achieve its investmentgoals.
Bringing onLew is a key strategic move to help grow DSS Wealth, even as theconfidence of some hedge fund managers hasfaltered during 2023 . The move comes with the objective ofpositioning Lew and DSS Wealth to aggressively develop in the sectorand advance DSS, Inc.’s overall strategy of incubating and spinningoff companies.
Lew added, "I was attracted to DSS because of the fact thatthere are many good underlying businesses here with experiencedmanagement teams that are in various stages of turnaround and growth.At the right point, executive management is committed to unlockingthose values via spinouts, sales, or mergers. The appreciationpotential for patient investors is considerable and I'm veryexcited to be able to play a role in building shareholdervalue.”
JasonGrady , Chief Operating Officer at DSS, Inc., commentedon Lew’s appointment , “His extensive experience, trackrecord, impressive credentials, and demonstrated expertise make him aninvaluable addition to our firm. We are confident that under hisleadership, our investment strategies will deliver exceptional resultsfor our clients.”
DSS, Inc. recently confirmedthe highly-anticipated spinoff in its biotech subsidiary, ImpactBiomedical . Investors will be awarded four shares ofImpact for every share they own in DSS once the company is spun off.The decision to spin off Impact is following the major announcementthat its subsidiary Global BioLife, Inc. has signed a licensingpartnership with ProPhase BioPharma Inc. (NASDAQ: PRPH) todevelop two promising therapeutics, Equivirand Linebacker , from Global BioLife.
Within the next fewfiscal quarters, DSS plans to spin off two other successfulsubsidiaries, the medical real estate investment trust, AAMI/AMRE , andthe financial services company, AmericanPacific Bancorp .
DSS, Inc. may offer risk-tolerant investors an attractiveapproach to building a diversified portfolio of future stock dividendsas the company executes its business plan of periodic subsidiaryspinoffs to its shareholders.
Learn moreabout DSS, Inc. by visiting its website .
DSS is amultinational company operating businesses within nine divisions:Product Packaging, Biotechnology, Direct Marketing, CommercialLending, Securities and Investment Management, Alternative Trading,Digital Transformation, Secure Living, and Alternative Energy. DSSstrategically acquires and develops assets to enrich the value of itsshareholders through calculated IPO spinoffs and a parametric sharedistribution strategy. Since 2019, under the guidance of newleadership, DSS has built the necessary foundation for achievablegrowth through the formation of a diversified portfolio of companiespositioned to drive profitability in multiple high growth sectors.These companies offer innovative, flexible, and real-world solutionsthat not only provide mutual benefits for businesses and theircustomers, but also create sustainable value and opportunity fortransformation.
This post contains sponsored advertisingcontent. This content is for informational purposes only and is notintended to be investing advice
ContactDetails
Rick Lutz- TraDigital IR
CompanyWebsite
Copyright (c) 2023 TheNewswire - All rights reserved.